SPONSORED CONTENT The U.S. drug pricing infrastructure is entering a transformative era. On August 1, 2025, the Health Resources and [...] …
More From Our Sponsor:
RxParadigm
RxParadigm
RxParadigm
Q: Tell us some interesting details about your company’s history. RxParadigm was built to stay ahead of the curve in healthcare’s most complex arenas. From our inception, we’ve focused on developing technology that simplifies drug pricing and compliance for manufacturers, pharmacies, and covered entities. By anticipating regulatory shifts and industry demands, we’ve positioned ourselves as a trusted partner for navigating change. That commitment is especially critical as January 1, 2026 approaches. With the launch of the Maximum Fair Price mandate and the 340B Rebate Model Pilot, the industry faces new...
Read More »SPONSORED CONTENT Time Inventory Management and 340B Clearinghouse The 340B program has experienced significant changes and disruptions over the past [...] …
RxParadigm
Q: Tell us some interesting details about your company’s history. RxParadigm, founded by industry veteran Mesfin Tegenu, is dedicated to developing technology solutions that streamline the drug supply chain and eliminate inefficiencies. In response to the growing challenges that 340B stakeholders face —along with ongoing debates over eligibility, legal challenges, legislative changes, and increasing restrictions—RxParadigm has built the nation’s first neutral 340B clearinghouse with the goal of bringing stability and transparency to the program. In order for a clearinghouse to get buy in from all parties — 340B covered entities,...
Read More »SPONSORED CONTENT Please join on us April 22nd at 1:00 p.m. EST for the third installment of RxParadigm’s 340B Clearinghouse [...] …
SPONSORED CONTENT The evolving landscape of pharmaceutical pricing and reimbursement models presents complex challenges for manufacturers and pharmacies. One of [...] …
SPONSORED CONTENT Please join on us October 8th at 2pm EST for our second installment of RxParadigm’s 340B Clearinghouse Webinar [...] …
SPONSORED CONTENT The 340B program remains essential in ensuring equitable access to crucial medications for vulnerable, underserved populations. The program [...] …
